DelveInsight’s “Japan Healthcare Outlook Report, 2025” provides comprehensive insights about the healthcare scenario, regulatory policies, and reimbursement landscape in Japan. The report also identifies key trends in the healthcare market and provides insights into the demographic and healthcare infrastructure of the country. Along with this, the report also provides a brief look into the trends and segmentation of the pharmaceutical and medical devices market of Japan.
To know more about Japan Healthcare Report: https://www.delveinsight.com/sample-request/japan-healthcare-outlook-report
Key Japan Healthcare Players:
- Takeda
- Daiichi Sankyo
- Pfizer
- Chugai
- Astellas
- Otsuka
- Merck & Co.
- Mitsubishi Tanabe
- GlaxoSmithKline
- Novartis
Request for Free Sample Report: https://www.delveinsight.com/sample-request/japan-healthcare-outlook-report
Japan Healthcare Report Highlights:
- Overview of the pharmaceutical and medical device markets
- An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Request for Free Sample Report: https://www.delveinsight.com/sample-request/japan-healthcare-outlook-report
Japan Healthcare Outlook:
Japan is an island country of East Asia in the northwest Pacific Ocean. It borders the Sea of Japan to the west and extends from the Sea of Okhotsk in the north to the East China Sea and Taiwan in the south. It has a population of 126 million, distributed on a territory of 377,915 square kilometers. In 2019, real GDP growth for Japan was 0.7%.
Since the establishment of the universal health insurance scheme in 1961, Japanese citizens have enjoyed a generous system under which the insured members have freedom to access health care facilities and a wide range of medical services for a relatively low co-payment. The Japanese administration system comprises three levels: central government; 47 prefectures; and 1,718 municipalities. The national health policy is implemented through local governments. Most basic health and welfare services, such as those for mother and child and the elderly, are provided by the municipal government.
Japan’s pharmaceutical market is one of the world’s biggest, with a value of around $95 billion, as per the country’s Ministry of Health, Labour and Welfare (MHLW). Japanese firms have a particularly strong standing in their home market, making up six of the country’s top ten pharma companies. Moreover, Takeda, Daiichi Sankyo, and Chugai are now significant global players in the pharmaceutical market.
Japan is considered to be the second largest mature pharmaceutical market in the world in terms of revenue. Japan’s pharmaceutical market value is set to grow in future, driven by new product launches and the healthcare burden of the country’s aging population. As of 2020, generics represent 80% of the total market. Over 35% of prescription drugs in Japan are imported from the USA, and this demand is expected to increase as the country has a rapidly aging population demanding new medicines for associated conditions.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/japan-healthcare-outlook-report
Table of Contents:
- Key Insights
- Japan at a Glance
- Executive Summary
- Assessment
- Market Access
- Japan PESTLE Analysis
- Driver and Barriers
- Appendix
- References
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
Download Detailed TOC Here: https://www.delveinsight.com/sample-request/japan-healthcare-outlook-report
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports medical device manufacturers, healthcare companies, and investors by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefit market analysis to accelerate business growth and overcome challenges with a practical approach.
Contact Us
Kanishk
